|
|
|
Volumn , Issue AUG., 2004, Pages 28-32
|
|
The prodrug approach to better targeting
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;
5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE;
ACICLOVIR DERIVATIVE;
ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE;
ANTICONVULSIVE AGENT;
ANTINEOPLASTIC AGENT;
BACLOFEN;
CANFOSFAMIDE;
CARBONIC ACID DERIVATIVE;
CYCLOPHOSPHAMIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EGLUMETAD;
ERYTHROMYCIN;
ESTER DERIVATIVE;
FOLIC ACID DERIVATIVE;
GABAPENTIN;
GAMMA GLUTAMYLBENZYLCYSTEINYLPHENYLGLYCINE DIETHYL ESTER;
GLUTAMATE RECEPTOR AGONIST;
GLUTATHIONE TRANSFERASE;
IFOSFAMIDE;
LH 7;
PEPTIDE TRANSPORTER 1;
PHOSPHORAMIDE MUSTARD;
PRODRUG;
TALAGLUMETAD;
TLK 199;
TRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALACICLOVIR;
XP 13512;
XP 19986;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
BREAST CANCER;
CANCER;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG ACCUMULATION;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG SCREENING;
DRUG SENSITIVITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG TARGETING;
ENZYME ACTIVATION;
FIRST PASS EFFECT;
HUMAN;
NONHUMAN;
PHARMACOKINETICS;
PHYSICAL CHEMISTRY;
RAT;
|
|
EID: 4444245259
PISSN: 14727463
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
